{
    "2021-03-16": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：CXO、医疗服务、生物制品等板块预计Q1高增长",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "医疗服务",
                        "生物制品",
                        "Q1高增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品",
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股反弹，金域医学、凯莱英、广联达、恩捷股份、公牛集团普涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "反弹",
                        "金域医学",
                        "凯莱英",
                        "广联达",
                        "恩捷股份",
                        "公牛集团",
                        "普涨"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "科技",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}